| Cervical obstruction complicating second-trimester abortion: treatment with misoprostol. | |
| | |
MedLine Citation:
|
PMID: 19155952 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Cervical cone biopsy or loop electrosurgical excision procedures (LEEP) may lead to cervical scarring, agglutination, or stenosis. Leiomyomas may also obstruct the lower uterine segment such that instruments cannot be passed from the vagina to the gestation. CASE: Two women requested second trimester abortion. Both women had undergone cervical LEEP. In addition, one woman had a 10-cm leiomyoma, which seemed to be obstructing the lower segment. In both, the external cervical os was essentially obliterated. After administration of misoprostol, the cervix softened markedly in 18-24 hours. In both women, the cervix dilated readily and allowed dilation and evacuation of the uterus. CONCLUSION: Misoprostol resulted in the ability to evacuate the uterus vaginally, in a situation that might have otherwise resulted in hysterotomy. |
| | |
Authors:
|
Lynn Borgatta; Raja Sayegh; Sarah J Betstadt; Phillip G Stubblefield |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Obstetrics and gynecology Volume: 113 ISSN: 0029-7844 ISO Abbreviation: Obstet Gynecol Publication Date: 2009 Feb |
Date Detail:
|
Created Date: 2009-01-21 Completed Date: 2009-02-23 Revised Date: 2009-10-26 |
Medline Journal Info:
|
Nlm Unique ID: 0401101 Medline TA: Obstet Gynecol Country: United States |
Other Details:
|
Languages: eng Pagination: 548-50 Citation Subset: AIM; IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, Massachusetts, USA. lynn.borgatta@bmc.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abortifacient Agents, Nonsteroidal
/
therapeutic use Abortion, Induced / methods* Cerclage, Cervical / adverse effects Cervix Uteri / pathology* Conization / adverse effects Female Humans Misoprostol / therapeutic use Pregnancy Pregnancy Trimester, Second* Vacuum Curettage* |
| Chemical | |
Reg. No./Substance:
|
0/Abortifacient Agents, Nonsteroidal; 59122-46-2/Misoprostol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hemolysis and elevated transaminases imitating severe preeclampsia.
Next Document: Cervical cancers after human papillomavirus vaccination.